Not on air · 2 of 3 networks checked
Novartis Belux
- novartis.be
- Pharmaceutical Manufacturing
- BE
- 156 employees
Novartis Belux’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 25. Watch Novartis Belux on any plan to get each new one in your feed.
Watchlist included in every plan
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksNov 2026 | Checked | Next step |
|---|---|---|---|---|---|
| None recorded | 0 | Checked 3 Nov 2026 | See all 25 ads → | ||
| Meta | None recorded | 0 | No active ads recorded on the Meta Ad Library | Checked 2 Nov 2026 | Collect them with the API → |
| Not checked | — |
Novartis Belux has no live LinkedIn ads. Its Facebook page had no active ads on 2 Nov 2026, and we recorded no Google ads on 6 Oct 2026.
Latest ads
- LINKEDIN · IMAGESince 26 Oct 2026
C3G care is evolving. Discover how earlier diagnosis and emerging treatment advances are reshaping the future of patient care. Join us on 16 November 2026 in Zaventem or online for an evening of scientific exchange on the latest insights in C3G, including complement-mediated pathophysiology, diagnostic considerations, unmet patient needs and the evolving treatment landscape. 📍Health Avenue, Zaventem 🕖19:00 - 22:00 🌍Featuring perspectives from Belgian faculty and an international expert speaker. 👉Register onsite: https://lnkd.in/dwCpf9mP 👉Register online: https://lnkd.in/dpGqgs7j Registration is reserved for healthcare professionals. #Nephrology #C3G #GlomerularDisease #KidneyHealth FA-11814516 - 15/10/2026
- LINKEDIN · IMAGESince 1 Oct 2026
Living with Chronic Spontaneous Urticaria (CSU) is about much more than symptoms. The disease can have a significant impact on everyday life, yet its burden often remains underrecognized 💔.(1) This World Urticaria Day, hear from two Belgian experts discussing the realities of CSU and why greater awareness matters, and why a better understanding of its impact matters for people living with the condition✨. 📽Watch the videos now and discover their insights. #WorldUrticariaDay #CSU #Immunology #ReliefAndHope Reference: (1) Maes I., Eysscher C., Forman M., Rey S., The burden of Chronic Spontaneous Urticaria in Belgium. Published February 2026.
- LINKEDIN · VIDEOSince 25 Sept 2026
🌍World C3G Day Early recognition and appropriate diagnostic work-up may support timely diagnosis and management of C3G.¹ Watch this video, in which Prof. Morelle shares his perspective on the main challenges around this ultra-rare kidney disease and highlights the importance of early diagnosis and kidney biopsy. As we look ahead, our commitment remains clear: advancing renal care, driving innovation, and working alongside the renal community to improve outcomes for patients today and tomorrow. 💙🩺🩵 #WorldC3GDay #C3G #Nephrology #RareKidneyDisease #KidneyHealth #RenalCare #Innovation #PatientFirst FA-11796413 - 22/09/2026 References 1. Establishing the Future Direction of Clinical Outcomes in C3 Glomerulopathy: Perspectives: From a Patient and a Physician - ScienceDirect13. Goodship TH, et al. Kidney Int. 2017;91:539–551
- LINKEDIN · CAROUSELSince 24 Sept 2026
🩸 Blood Cancer Awareness Month Living with Chronic Myeloid Leukemia (CML) can raise many questions, from diagnosis to daily life. At Novartis, we believe that access to clear, reliable information can help people feel more informed and empowered throughout their journey. This month, we're highlighting educational resources designed to support people living with CML through relatable stories, practical insights and available patient tools. Swipe to discover more. #BloodCancerAwarenessMonth #CML #BloodCancer #PatientEmpowerment #PatientEducation #ReimaginingMedicine #NovartisBeLux FA-11795117 – 21/09/2026
- LINKEDIN · IMAGESince 9 Jun 2026
Connecting with the hematology community from BeLux at #EHA2026 Are you joining the European Hematology Association Congress in Stockholm this week? We would be pleased to welcome hematology colleagues from Belgium and Luxembourg to our Novartis-sponsored satellite symposium: 👉 “Chronic myeloid leukemia beyond survival: How do we achieve quality survivorship?” 📅 Friday 12 June 2026 🕙 10:00–11:30 CEST 📍 K1 Auditorium, Stockholmsmässan Congress Center 👉 If you are attending #EHA2026, we warmly invite you to join us. #Hematology #CML #EHA2026 #Belgium #Luxembourg
- LINKEDIN · CAROUSELSince 1 Jun 2026
For people living with hidradenitis suppurativa (HS), the disease involves much more than what is visible on the surface. Its impact can be felt in everyday moments, affecting confidence and overall well-being.(1,2) And for many, the journey to diagnosis is long.(3) Earlier recognition can change the HS journey.(4) This HS Awareness Week, Novartis together with the Belgian HS Working Group spotlight the importance of early recognition and timely care for HS-patients. #HSAwarenessWeek #HS #Dermatology References: 1. Nguyen TV, Damiani G, Orenstein LAV, Hamzavi I, Jemec GB. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life. J Eur Acad Dermatol Venereol. 2021;35(1):50-61. 2. Perche PO et al. Cureus. 2022;14(5):e25292. 3. Saunte DML, et al. Br J Dermatol. 2015;173:1546-49. 4. Marzano AV, et al. Br J Dermatol. 2021;184:133-40. FA-11696967-1 / 02.06.2026
6 of 25 adsSign up to see every Novartis Belux ad, filter by format and date, and get alerts on new ones.
See all 25 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.